Treatment - Other
Lakshmi Chennapragada, M.A.
Research Coordinator
James J Peters VAMC
New York, New York
Sarah R. Sullivan, M.S.
Graduate Student Researcher
Hunter College, City University of New York
Bronx, New York
Kyra Hamerling-Potts, B.A.
Clinical Research Coordinator
James J. Peters VA Medical Center
NEW YORK, New York
Hannah N. Tran, B.A., M.A.
Graduate Research Assistant
Columbia University
Bakersfield, California
Jake R. Szeszko, N/A, None
Research Assistant
James J Peters VAMC
Baltimore, Maryland
Joseph Wrobleski, B.A.
Health Science Specialist
James J. Peters VA Medical Center
New York, New York
Emily L. Mitchell, B.A.
Clinical Research Coordinator
James J. Peters VA Medical Center
Bronx, New York
Samantha Walsh, M.A., Other
Manager of Information & Education Services
Icahn School of Medicine at Mount Sinai
New York, New York
Marianne S. Goodman, M.D.
Professor
Icahn School of Medicine at Mount Sinai
Bronx, New York
Objective: Preliminary research indicates that the COVID-19 illness has short- and long-term effects on the mental well-being of patients. Thus, there is a need for targeted mental health interventions to support this patient population. This scoping review aims to examine the current state of the literature regarding treatment for depression symptoms in COVID-19 patients, and provide informed suggestions for future research and treatment efforts.
Methods: Select databases were searched on 7/1/2021. Full-text articles involved 1) mental health treatment 2) suicide and/or depression outcomes, 3) a quasi-experimental research trial, and 4) a primary analysis. 11 articles were included in this review.
Results: The studies spanned 5 countries, and demonstrated immediate positive effects of mental health treatments and tele-health as a treatment modality for depression in COVID-19 patients. 6 studies were randomized controlled trials. Various treatments were administered, including cognitive behavior therapy, mindfulness, and muscle relaxation. Most of the interventions were conducted in in-patient units and focused on acute symptoms. The review found limitations in the design and description of methodology in many studies, which affects the generalizability and replicability of positive findings. Only two studies included a post-intervention follow-up assessment and only one study included a suicide risk assessment.
Conclusion: Preliminary research into in-person and tele-health treatment for depression in COVID-19 patients is promising. There is a pressing need for more research in the area, with greater rigor in study methodology, and particularly for treatments that target long-term symptoms and suicidality, and are administered in outpatient settings.